Skip to main content
. 2021 Feb 24;22(6):890–900. doi: 10.3348/kjr.2020.0538

Table 1. Patient Characteristics (n = 312).

Variables
Age (years) 52.7 ± 14.3
Male, n (%) 227 (72.8)
Body surface area (m2) 1.7 ± 0.2
Hypertension, n (%) 97 (31.1)
Hyperlipidemia, n (%) 52 (16.7)
Diabetes mellitus, n (%) 23 (7.4)
COPD, n (%) 13 (4.2)
Smoking, n (%) 117 (37.5)
NYHA class, n (I/II/III/IV) 149/97/58/8
Coronary artery disease, n (%) 29 (9.3)
Coronary calcium score, median (range) 0 (0–3,660)
Valve calcium score, median (range) 615 (0–14,073)
BAV morphology
 Raphe+/raphe–, n (%) 185 (59.3)/127 (40.7)
 BAV-AP/BAV-RL, n (%) 188 (60.3)/124 (39.7)
Aortic phenotype, n (%)
 Normal 39 (12.5)
 Root dilatation 33 (10.6)
 Mid ascending aorta dilatation 45 (14.4)
 Combined root and ascending aorta dilatation 195 (62.5)
Aorta aneurysm, n (%) 72 (23.1)
AS, n (%)
 None or mild
 Moderate or severe 171 (54.8)
AR, n (%)
 None or mild 212 (67.9)
 Moderate or severe 100 (32.1)
Aortic root
 Dimension (mm) 39.6 ± 6.1
 Size index (cm/m2) 2.3 ± 0.3
 Size index > 2.1 cm/m2 228 (73.1)
Tubular portion
 Dimension (mm) 43.0 ± 7.6
 Size index (cm/m2) 2.5 ± 0.5
 Size index > 2.1 cm/m2 240 (76.9)
Echocardiographic data
 LVEF (%) 63.1 ± 12.1
 End diastolic volume (mL) 148.4 ± 73.4
 End systolic volume (mL) 57.8 ± 44.8
AR/AS/ASR/Normal, n 104/97/92/19
Aortic valve surgery, n (%) 240 (76.9)
Aortic surgery, n (%) 121 (38.8)

AP = anterior-posterior, AR = aortic regurgitation, AS = aortic stenosis, ASR = aortic stenosis and regurgitation, BAV = bicuspid aortic valve, COPD = chronic obstructive pulmonary disease, LVEF = left ventricular ejection fraction, NYHA = New York Heart Association, RL = right-left